IP Library Granted Patent US 8,568,364
Granted Patent B2
US 8,568,364 · App. 13/139,919 · Granted Oct 29, 2013

Drug delivery device

Inventor: David Plumptre (Droitwich Spa Worcestershire, GB)
Assignee: Sanofi-Aventis Deutschland GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,364
App. No.
13/139,919
Granted
Oct 29, 2013
Kind
B2
Abstract

A drug delivery device ( 1 ) comprises a housing ( 2 ) and a cap ( 3 ) attachable onto the housing ( 2 ). The cap ( 3 ) comprises one or more snap features ( 33 ) to attach the cap ( 3 ) onto the housing ( 2 ) and one or more orientation features ( 34 ) to define the orientation of the cap ( 3 ) relative to the housing ( 2 ). At least one of the orientation features ( 34 ) is located at a rigid part of the cap ( 3 ) and at least one of the snap features ( 34 ) is located at a less rigid part of the cap ( 3 ).

Claims (34)

1. A drug delivery device comprising:

a housing having a distal end,

a cap having a rigid part and a second part less rigid than the rigid part, where the cap is attachable to the distal end of the housing and configured to cover a cartridge holder attached to the distal end of the housing,

wherein the cap comprises one or more snap features to attach the cap onto the housing and one or more orientation features to define the orientation of the cap relative to the housing when attached to the housing,

wherein at least one of the one or more orientation features is located at the rigid part of the cap and at least one of the one or more snap features is located at the second less rigid part of the cap.

2. The drug delivery device according to claim 1 ,

wherein the one or more orientation features allow a full assembly or attachment of the cap and the housing only in a single orientation of the cap relative to the housing.

3. The drug delivery device according to claim 1 having a longitudinal axis (I),

wherein the at least one snap feature located at the second less rigid part of the cap and the at least one orientation feature located at the rigid part of the cap have an offset according to the longitudinal axis (I).

4. The drug delivery device according to claim 3 ,

comprising a plurality of orientation features having an angular offset around the longitudinal axis (I).

5. The drug delivery device according to claim 1 ,

wherein the cap comprises an open end and a closed end and

wherein at least one of the one or more snap features is located near the open end of the cap and at least one of the one or more orientation features is displaced from this snap feature in a direction towards the closed end of the cap.

6. The drug delivery device according to claim 5 ,

wherein at least one of the one or more orientation features is located at the open end of the cap.

7. The drug delivery device according to claim 6 ,

wherein the cap comprises at least one protrusion at its open end.

8. The drug delivery device according to claim 7 ,

wherein the cap comprises two protrusions at its open end which are located equiangular around the longitudinal axis (I).

9. The drug delivery device according to claim 7 ,

wherein at least one of the one or more snap features is located at the protrusion.

10. The drug delivery device according to claim 1 ,

wherein the housing comprises one or more mating snap features engageable with at least one of the one or more snap features and one or more mating orientation features interacting with at least one of the one or more orientation features.

11. The drug delivery device according to claim 10 ,

wherein the mating orientation features comprise a lead-in to assist the assembly or attachment of the cap and the housing.

12. The drug delivery device according to claim 1 ,

wherein the housing comprises a cartridge holder configured to receive a cartridge containing a drug and wherein the cap can be attached such that it covers at least a part of the cartridge holder.

13. The drug delivery device according to claim 1 ,

wherein the cap comprises a window.

14. The drug delivery device according to claim 13 ,

wherein one of or both a cartridge and a cartridge holder have an indication which is visible through the window when the cap is attached to the housing.

15. The drug delivery device according to claim 1 ,

wherein the drug delivery device is a pen-type injection device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2011
From: PLUMPTRE, DAVID
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 027043/0127 →
Priority Claims (1)
EP 08022318 · Dec 23, 2008 · regional
Continuity (1)
Related Publication 20120022462A1 · Jan 26, 2012